The FDA making it easier to compound BPC-157 does not change the evidence gap Attia describes
Common symptoms include anemia, fatigue, weakness, lightheadedness, pale skin, and neurological issues such as tingling or numbness in the hands and feet, muscle weakness, memory problems, poor appetite, and mood changes
While a balanced diet or oral supplements are often sufficient for maintaining adequate B12 levels, certain conditions may necessitate vitamin B12 injections
As a partial sequence of the larger body protection compound discovered in gastric secretions, BPC-157 represents a stable peptide fragment that retains the protective and regenerative properties of the parent molecule
Prescribers should be mindful of the impacts that delayed gastric emptying and reduced blood sugar can have with other medications